CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
prednisone in symptomatic bone-only metastatic castration-resistant prostate cancer (mCRPC)Open-label, randomized phase II trial in ...
Phase 2
Milano, Italy and 14 other locations
and abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) who have received no prior cytotoxic chemo ...
Phase 3
Milano, Italy and 131 other locations
The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutam...
Phase 2
Cremona, Italy and 225 other locations
Phase 3 Trial Comparing the Safety and Efficacy of 177Lu-PSMA-I\&T versus Hormone Therapy in Patients with Metastatic Castration-Resistant Prostate...
Phase 3
Milan, Italy and 51 other locations
pharmacodynamics, and preliminary efficacy of AZD5305 when given in combination with new hormonal agents (NHAs) in patients with Metastatic Prostate...
Phase 1, Phase 2
Milano, Italy and 26 other locations
is to evaluate the effectiveness, safety and tolerability of nivolumab followed by ipilimumab, in subjects with metastatic castration resistant prostate...
Phase 2
Milano, Italy and 58 other locations
The purpose of this study was to evaluate the efficacy of enzalutamide plus androgen deprivation therapy (ADT) as measured by radiographic progressio...
Phase 3
Milano, Lombardia, Italy and 202 other locations
hormonal therapy (NHT) in men with metastatic castration-resistant prostate cancer (mCRPC) who have previously been treated with on ...
Phase 3
Milan, Italy and 278 other locations
The intention of the study is to demonstrate superiority of Saruparib (AZD5305) + physician's choice NHA relative to placebo + physician's choice NHA...
Phase 3
Milano, Italy and 394 other locations
The primary objective of the trial is to assess if upfront combination of enzalutamide and Ra223 improves radiological progression-free survival (rPF...
Phase 3
Milano, Italy and 63 other locations
Clinical trials
Research sites
Resources
Legal